Ignite Creation Date:
2025-12-25 @ 12:55 AM
Ignite Modification Date:
2026-05-26 @ 2:57 PM
Study NCT ID:
NCT05538767
Status:
COMPLETED
Last Update Posted:
2023-06-15
First Post:
2022-09-09
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efficacy and Safety of Emodepside in Adolescents and Adults Infected With Hookworm
Sponsor:
Jennifer Keiser
Organization:
Study Overview
Official Title:
Efficacy and Safety of Emodepside in Adolescents and Adults Infected With Trichuris Trichiura and Hookworm: Randomized Two Stages Phase II Seamless Adaptive Controlled Single-blind Trials
Status:
COMPLETED
Status Verified Date:
2023-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To compare the efficacy and safety of emodepside to that of albendazole (Zentel®) in participants aged 12-60, inclusive, infected with hookworm.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: